Clinical Trials Sponsored by Polish Adult Leukemia Group, Gliwice, Poland

Total 5 results

Polish Adult Leukemia Group

Recruiting

A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients ≤ 60 Years Old (PALG-AML1/2016)

Acute Myeloid Leukemia

United States, Poland
Polish Adult Leukemia Group

Completed

Comorbidity Burden and Use of Concomitant Medications at CML Diagnosis

Chronic Myeloid Leukemia
Maria Sklodowska-Curie Memorial Cancer Center and...
Polish Adult Leukemia Group

Unknown

Personalized Therapy of Precursor Lymphoid Neoplasms

Precursor Lymphoid Neoplasms

Poland
dr hab. n. med. Agnieszka Wierzbowska
Copernicus Memorial Hospital; Polish Adult Leukemia Group

Unknown

Role of the Therapy Tailored to Risk Factors in Treating Adult Patients (≤60) With Acute Myeloid Leukemia (PALG-AML2012)

Acute Myeloid Leukemia

Poland
Goethe University
Stichting Hemato-Oncologie voor Volwassenen Nederland; Polish Adult Leukemia... and other collaborators

Terminated

Panobinostat Maintenance After HSCT fo High-risk AML and MDS

Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukaemia (AML)

Germany, Netherlands

3

Subscribe